181 related articles for article (PubMed ID: 21337884)
1. Development of a Bayesian Belief Network Model for personalized prognostic risk assessment in colon carcinomatosis.
Stojadinovic A; Nissan A; Eberhardt J; Chua TC; Pelz JO; Esquivel J
Am Surg; 2011 Feb; 77(2):221-30. PubMed ID: 21337884
[TBL] [Abstract][Full Text] [Related]
2. Treatment of peritoneal carcinomatosis from colonic cancer by cytoreduction, peritonectomy and hyperthermic intraperitoneal chemotherapy (HIPEC). Experience of ten years.
Vaira M; Cioppa T; D'Amico S; de Marco G; D'Alessandro M; Fiorentini G; De Simone M
In Vivo; 2010; 24(1):79-84. PubMed ID: 20133981
[TBL] [Abstract][Full Text] [Related]
3. Clinical decision support and individualized prediction of survival in colon cancer: bayesian belief network model.
Stojadinovic A; Bilchik A; Smith D; Eberhardt JS; Ward EB; Nissan A; Johnson EK; Protic M; Peoples GE; Avital I; Steele SR
Ann Surg Oncol; 2013 Jan; 20(1):161-74. PubMed ID: 22899001
[TBL] [Abstract][Full Text] [Related]
4. Evaluation of a peritoneal surface disease severity score in patients with colon cancer with peritoneal carcinomatosis.
Pelz JO; Stojadinovic A; Nissan A; Hohenberger W; Esquivel J
J Surg Oncol; 2009 Jan; 99(1):9-15. PubMed ID: 18937291
[TBL] [Abstract][Full Text] [Related]
5. Impact of the peritoneal surface disease severity score on survival in patients with colorectal cancer peritoneal carcinomatosis undergoing complete cytoreduction and hyperthermic intraperitoneal chemotherapy.
Chua TC; Morris DL; Esquivel J
Ann Surg Oncol; 2010 May; 17(5):1330-6. PubMed ID: 20033321
[TBL] [Abstract][Full Text] [Related]
6. Survival prognostic factors in patients with colorectal peritoneal carcinomatosis treated with cytoreductive surgery and intraoperative hyperthermic intraperitoneal chemotherapy: a single institution experience.
Nikolic S; Dzodic R; Zegarac M; Djurisic I; Gavrilovic D; Vojinovic V; Kocic M; Santrac N; Radlovic P; Radosavljevic D; Pupic G; Martinovic A
J BUON; 2014; 19(1):66-74. PubMed ID: 24659645
[TBL] [Abstract][Full Text] [Related]
7. Prognostic value of circulating tumor markers in patients with pseudomyxoma peritonei treated with cytoreductive surgery and hyperthermic intraperitoneal chemotherapy.
Baratti D; Kusamura S; Martinetti A; Seregni E; Laterza B; Oliva DG; Deraco M
Ann Surg Oncol; 2007 Aug; 14(8):2300-8. PubMed ID: 17510772
[TBL] [Abstract][Full Text] [Related]
8. Hyperthermic intraperitoneal chemotherapy with oxaliplatin for peritoneal carcinomatosis arising from appendix: preliminary results of a survival analysis.
Marcotte E; Sideris L; Drolet P; Mitchell A; Frenette S; Leblanc G; Leclerc YE; Dubé P
Ann Surg Oncol; 2008 Oct; 15(10):2701-8. PubMed ID: 18654822
[TBL] [Abstract][Full Text] [Related]
9. Quantitative intra-operative assessment of peritoneal carcinomatosis - a comparison of three prognostic tools.
Swellengrebel HA; Zoetmulder FA; Smeenk RM; Antonini N; Verwaal VJ
Eur J Surg Oncol; 2009 Oct; 35(10):1078-84. PubMed ID: 19285828
[TBL] [Abstract][Full Text] [Related]
10. Cytoreductive surgery (peritonectomy procedures) combined with hyperthermic intraperitoneal chemotherapy (HIPEC) in the treatment of diffuse peritoneal carcinomatosis from ovarian cancer.
Di Giorgio A; Naticchioni E; Biacchi D; Sibio S; Accarpio F; Rocco M; Tarquini S; Di Seri M; Ciardi A; Montruccoli D; Sammartino P
Cancer; 2008 Jul; 113(2):315-25. PubMed ID: 18473354
[TBL] [Abstract][Full Text] [Related]
11. Delay of cytoreductive surgery and heated intraperitoneal chemotherapy in patients with appendiceal neoplasm.
El Halabi H; MacDonald R; Studeman K; Francis J; Nieroda C; Gushchin V; Sardi A
Am Surg; 2012 Jul; 78(7):745-8. PubMed ID: 22748531
[TBL] [Abstract][Full Text] [Related]
12. Complete cytoreduction offers longterm survival in patients with peritoneal carcinomatosis from appendiceal tumors of unfavorable histology.
Omohwo C; Nieroda CA; Studeman KD; Thieme H; Kostuik P; Ross AS; Holter DR; Gushchin V; Merriman B; Sardi A
J Am Coll Surg; 2009 Sep; 209(3):308-12. PubMed ID: 19717034
[TBL] [Abstract][Full Text] [Related]
13. Time-dependent estimates of recurrence and survival in colon cancer: clinical decision support system tool development for adjuvant therapy and oncological outcome assessment.
Steele SR; Bilchik A; Johnson EK; Nissan A; Peoples GE; Eberhardt JS; Kalina P; Petersen B; Brücher B; Protic M; Avital I; Stojadinovic A
Am Surg; 2014 May; 80(5):441-53. PubMed ID: 24887722
[TBL] [Abstract][Full Text] [Related]
14. Cytoreductive surgery and perioperative intraperitoneal chemotherapy for isolated colorectal peritoneal carcinomatosis: experimental therapy or standard of care?
Yan TD; Morris DL
Ann Surg; 2008 Nov; 248(5):829-35. PubMed ID: 18948811
[TBL] [Abstract][Full Text] [Related]
15. Management of pseudomyxoma peritonei by cytoreduction+HIPEC (hyperthermic intraperitoneal chemotherapy): results analysis of a twelve-year experience.
Vaira M; Cioppa T; DE Marco G; Bing C; D'Amico S; D'Alessandro M; Fiorentini G; DE Simone M
In Vivo; 2009; 23(4):639-44. PubMed ID: 19567401
[TBL] [Abstract][Full Text] [Related]
16. Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy in the management of peritoneal carcinomatosis. Preliminary results and cost from two centers in Greece.
Spiliotis J; Tentes AA; Vaxevanidou A; Korakianitis OS; Rogdakis A; Mirelis CG; Datsis AC; Kekelos S
J BUON; 2008; 13(2):205-10. PubMed ID: 18555466
[TBL] [Abstract][Full Text] [Related]
17. Safety of gastric resections during cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for peritoneal carcinomatosis.
Piso P; Slowik P; Popp F; Dahlke MH; Glockzin G; Schlitt HJ
Ann Surg Oncol; 2009 Aug; 16(8):2188-94. PubMed ID: 19408049
[TBL] [Abstract][Full Text] [Related]
18. Peritoneal pseudomyxoma: results of a systematic policy of complete cytoreductive surgery and hyperthermic intraperitoneal chemotherapy.
Elias D; Honoré C; Ciuchendéa R; Billard V; Raynard B; Lo Dico R; Dromain C; Duvillard P; Goéré D
Br J Surg; 2008 Sep; 95(9):1164-71. PubMed ID: 18690633
[TBL] [Abstract][Full Text] [Related]
19. Histological response of peritoneal carcinomatosis after hyperthermic intraperitoneal chemoperfusion (HIPEC) in experimental investigations.
Pelz JO; Doerfer J; Dimmler A; Hohenberger W; Meyer T
BMC Cancer; 2006 Jun; 6():162. PubMed ID: 16792796
[TBL] [Abstract][Full Text] [Related]
20. Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for peritoneal carcinomatosis from colorectal and gastrointestinal origin shows acceptable morbidity and high survival.
Hagendoorn J; van Lammeren G; Boerma D; van der Beek E; Wiezer MJ; van Ramshorst B
Eur J Surg Oncol; 2009 Aug; 35(8):833-7. PubMed ID: 19019619
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
